CAR-NK/CAR-T Cells: Emerging Immunotherapy of Cancer
Authors:
- 13 October 2024
- book chapter
- Published by Springer Nature
- p. 229-265
Abstract
No abstract availableKeywords
This publication has 229 references indexed in Scilit:
- Advancing to the era of cancer immunotherapyCancer Communications, 2021
- CAR‐NK cells: the next wave of cellular therapy for cancerClinical & Translational Immunology, 2021
- CD276 as a novel CAR NK‐92 therapeutic target for neuroblastomaAdvances in Cell and Gene Therapy, 2020
- CD33‐Targeted Therapies: Beating the Disease or Beaten to Death?The Journal of Clinical Pharmacology, 2020
- Surmounting the obstacles that impede effective CAR T cell trafficking to solid tumorsJournal of Leukocyte Biology, 2020
- TRUCKS, the fourth‐generation CAR T cells: Current developments and clinical translationAdvances in Cell and Gene Therapy, 2020
- Mechanisms of natural killer cell-mediated cellular cytotoxicityJournal of Leukocyte Biology, 2019
- Effect of tumor cells and tumor microenvironment on NK‐cell functionEuropean Journal of Immunology, 2014
- Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. II. Characterization of effector cellsInternational Journal of Cancer, 1975
- „Natural”︁ killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotypeEuropean Journal of Immunology, 1975